Juan is a successful tech entrepreneur who has launched more than 100 start-ups, including the first high-tech start-up accelerator in Southern Europe. He received an MBA from the Massachusetts Institute of Technology (MIT), an M.S. in Economics from Ecole Centrale in Paris, and M.S. and B.S. in Industrial Engineering from Universidad de Sevilla. He was selected as an Endeavor Entrepreneur in 2021.

Antonio brings more than 25 years of experience launching and leading new technology companies, including one publicly-traded on the NASDAQ. In addition to his experience as an entrepreneur and chief executive, he spent 8 years at McKinsey & Co where he leaded the EU Telco practice. He received an MBA from the Institut Europeen d’Administration des Affaires (INSEAD).

Christian brings more than 15 years of experience in Life Sciences to his role. Formerly, he was a member of Boston Consulting Group’s Operations and Healthcare team and led the company’s recruiting efforts. He received an MBA from the Institut Europeen d’Administration des Affaires (INSEAD), and is a member of Handelsblatt Health Circle and was selected as Endeavor Entrepreneur in 2021.

Kristi brings more than 10 years of experience in biotechnology to her role. Her areas of expertise and study include genetics, cancer biology, liquid biopsy, method development and data analysis. At Universal DX, she is leading a multidisciplinary team in diagnostic product development focusing on GI tract cancers. She received a B.S. in Genetics and a M.S. in Biotechnology & Biochemistry from Tallinn University of Technology.

Ignacio brings more than 10 years of experience in financial services and management consulting to his role. Formerly, he held roles at global financial consulting firms Barclays Capital, PwC and Kearney. He received a B.S. in Business Administration from ICADE (Madrid) and HEC Montreal, an MBA from the Institut Europeen d’Administration des Affaires (INSEAD). He was selected at Singularity University’s Global Startup Program 2019 with UDX.

Alvaro brings more than 10 years of experience in management consulting, with a focus on advising tech start-ups. He received an MBA from San Telmo Business School and also completed The Executive Program on Entrepreneurship at MIT. He received a B.A. in Business Administration from the University of North Florida.

Co-Chair of the New York Citywide Colorectal Cancer Control Coalition risk assessment and screening committee. Former chair of the Diversity, Equity, and Inclusion Committee for the American College of Gastroenterology (ACG).

Former vice chair of the National Comprehensive Cancer Network guideline committees for genetic/high-risk familial assessment and screening for colorectal cancer.

Head of Colorectal Cancer Screening Program

Former Chairman DadeBehring Inc. US.

Chief of the Department of Pathology at the Beth Israel Deaconess Medical Center (BIDMC); Specialized in diagnosing gastrointestinal diseases such as colorectal and pancreatic cancers.

Scientist/Entrepreneur.

Medical Director. Head of Colorectal Cander Screening Program.

Director of the Institute of Oncology, ESMO President.

Medical Director. Center for Endoscopy UKE Hamburg; Member of Global Clinical Trial Board Epigenomics

Medical Director. Gastroenterology of Sana Klinikum Lichtenberg, Site Principal Investigator Germany; Member of Global Clinical Trial Board Epigenomics.

Colorectal Surgeon and Clinical Senior Lecturer in Colorectal Surgery. Member of Faculty of Medicine, Department of Surgery & Cancer at Imperial College London.

Physician and clinical researcher. Director of Gastroenterology outcomes Research and co-director of translational research education and careers in the Clinical and Translational Science Institute.

Professor of Medicine, Chief Division of Gastroenterology